American Journal of Health-System Pharmacy : AJHP This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Correction to: A review of fecal microbiota, live-jslm for the prevention of recurrent Clostridioides difficile infection
Am J Health Syst Pharm. 2024 Apr 30:zxae113. doi: 10.1093/ajhp/zxae113. Online ahead of print.NO ABSTRACTPMID:38687627 | DOI:10.1093/ajhp/zxae113 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - April 30, 2024 Category: Drugs & Pharmacology Source Type: research

Targeted and immunotherapy for the management of advanced urothelial carcinoma of the bladder
CONCLUSION: Six targeted and immunotherapeutic agents have been approved for patients with advanced urothelial bladder cancer. They all have demonstrated activity in patients for whom disease has progressed during or after platinum-based therapy. Pembrolizumab, with and without enfortumab, has demonstrated first-line activity, and avelumab is a key maintenance therapy after first-line treatment. The results of additional clinical trials should provide evidence to establish the exact role in therapy of each agent in patients with advanced disease.PMID:38679913 | DOI:10.1093/ajhp/zxae090 (Source: American Journal of Health-S...
Source: American Journal of Health-System Pharmacy : AJHP - April 29, 2024 Category: Drugs & Pharmacology Authors: Robert J Cersosimo Source Type: research

Approaches to medication history taking in different hospital settings: A scoping review
CONCLUSION: Most approaches focused on pharmacy staff, which are associated with considerable cost and resources. Therefore, IT-based approaches and patient engagement should be investigated as cost-effective alternatives and tested for superiority in the same setting. Reporting guidelines and standardized methodology are needed to improve the comparability of such studies.PMID:38660785 | DOI:10.1093/ajhp/zxae112 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - April 25, 2024 Category: Drugs & Pharmacology Authors: Theresa Terstegen Christina Niestroj Julia Stangl Camilo Scherkl Benedict Morath Walter E Haefeli Hanna M Seidling Source Type: research

The pharmacist's role in optimizing medication management before, during, and after minimally invasive and bariatric surgery
CONCLUSION: Pharmacist contributions to perioperative medication management for MIS procedures can improve care as surgical patients navigate transitions through the perioperative setting. Pharmacists can further incorporate medication expertise through development and implementation of institutional MIS protocols within the context of ERPs. As such, any pharmacist should feel empowered to aid in the care of surgical patients.PMID:38662339 | DOI:10.1093/ajhp/zxae111 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - April 25, 2024 Category: Drugs & Pharmacology Authors: Laura M Ebbitt Lynn E Kassel Jeffrey J McKenzie Nicole M Palm April N Smith Source Type: research

National trends in prescription drug expenditures and projections for 2024
CONCLUSION: For 2024, we expect overall prescription drug spending to rise by 10.0% to 12.0%, whereas in clinics and hospitals we anticipate an 11.0% to 13.0% increase and a 0% to 2.0% increase, respectively, compared to 2023. These national estimates of future pharmaceutical expenditure growth may not be representative of any health system because of the myriad of local factors that influence actual spending.PMID:38656319 | DOI:10.1093/ajhp/zxae105 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - April 24, 2024 Category: Drugs & Pharmacology Authors: Eric M Tichy James M Hoffman Mina Tadrous Matthew H Rim Sandra Cuellar John S Clark Mary Kate Newell Glen T Schumock Source Type: research

Projected prescription drug expenditures in 2024: Looking ahead to the inflation reduction era
Am J Health Syst Pharm. 2024 Apr 24:zxae104. doi: 10.1093/ajhp/zxae104. Online ahead of print.ABSTRACTIn an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.PMID:38656543 | DOI:10.1093/ajhp/zxae104 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - April 24, 2024 Category: Drugs & Pharmacology Authors: Inmaculada Hernandez Source Type: research

The efficacy and safety of direct oral anticoagulants in the treatment of the acute phase of heparin-induced thrombocytopenia: A systematic review
CONCLUSION: Data from 12 publications and across 36 patients suggests that the use of DOACs in the acute phase of HIT may be a safe and efficacious treatment option with favorable ease of monitoring and management.PMID:38651828 | DOI:10.1093/ajhp/zxae109 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - April 23, 2024 Category: Drugs & Pharmacology Authors: Cooper Sadowski Justin P Reinert Source Type: research